David Michael Remick

USPTO Granted Patents = 12 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 26(Granted Patents)

Location History:

Indianapolis, IN (US) (2023)
Fishers, IN (US) (2004 - 2024)

Company Filing History:

11 out of 4,442

Eli Lilly and Company

patents

1 out of 947

Chugai Seiyaku Kabushiki Kaisha

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486249 - SSTR4 agonist salts (2025-12-02),

2. 12365682 - Process to make GLP1 RA and intermediates therefor (2025-07-22),

3. 12102610 - Treprostinil salt (2024-10-01),

4. 11926634 - Processes for the preparation of selective estrogen receptor degraders (2024-03-12),

5. 11834435 - SSTR4 agonist salts (2023-12-05),

6. 11820754 - Polymorphs of an SSAO inhibitor (2023-11-21),

7. 10787460 - (E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-carboxylate for inhibiting CDK7 (2020-09-29),

8. 10011610 - Selective BACE1 inhibitors (2018-07-03),

9. 8299060 - [object Object] (2012-10-30),

10. 7691827 - Amide prodrug of gemcitabine, compositions and use thereof (2010-04-06),

11. 7320994 - Triazole derivatives as tachykinin receptor antagonists (2008-01-22),

12. 6730792 - &bgr;3 adrenergic agonists (2004-05-04),

Title: The Innovative Journey of David Michael Remick

Introduction

David Michael Remick is a prominent inventor based in Fishers, Indiana, known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, he has made remarkable strides in the development of innovative compounds and processes.

Latest Patents

Among his latest patents is a process to make GLP1 RA and intermediates therefor. This invention relates to the synthesis of a complex compound that has potential applications in medical treatments. Another notable patent is for a novel salt of treprostinil, which includes methods of its preparation and use. These patents reflect his expertise in synthesizing advanced pharmaceutical compounds.

Career Highlights

David has worked with esteemed companies such as Eli Lilly and Company and Chugai Seiyaku Kabushiki Kaisha. His experience in these organizations has allowed him to hone his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Throughout his career, David has collaborated with talented individuals, including David Andrew Coates and Britta Evers. These partnerships have fostered innovation and have been instrumental in the development of his patented inventions.

Conclusion

David Michael Remick's journey as an inventor showcases his dedication to advancing pharmaceutical science through innovative solutions. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.